1 Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin-Madison.
J Manag Care Spec Pharm. 2016 Jul;22(7):801-7. doi: 10.18553/jmcp.2016.22.7.801.
The Centers for Medicare & Medicaid Services (CMS) include measures of medication adherence within its Medicare Part D star ratings program. These adherence measures have motivated the development of new methods to improve patient adherence. Automatic prescription refill programs in community pharmacies are an intervention that has seen widespread adoption in recent years. These automatic refill programs anticipate and initiate prescription refills on a standardized, recurrent basis. As a result, prescription refills may be filled before a patient typically might initiate a refill. This study measures the effect of an automatic prescription refill program on 3 adherence metrics used by CMS within Medicare Part D star ratings.
To compare the value of Medicare Part D adherence metrics for an automatic prescription refill program relative to standard prescription refills.
Prescription dispensing data (January 1, 2014-December 31, 2014) from a chain of 29 pharmacies in a midwestern state were used to conduct this analysis. A post-only, quasi-experimental design separated patients into automatic and standard prescription refill cohorts. Refill adherence was calculated using proportion of days covered (PDC) for each of the 3 adherence metrics used by CMS for statins, renin angiotensin aldosterone system antagonists (RASA), and noninsulin diabetes medications. The adherence rate was defined as the proportion of patients with a PDC ± 80%. Inclusion criteria for patients followed the Pharmacy Quality Alliance technical specifications. Chi-square analysis and multiple logistic regression were used to examine differences in PDC > 80% between the 2 study cohorts.
There were 1,018, 1,006, and 368 patients for the automatic refill cohort and 3,928, 3,409, and 1,207 patients for the standard refill cohort in the statin, RASA, and diabetes adherence metrics, respectively. The mean age [SD] of patients was between 79.2 [±8.5] and 80.8 [±9.9] years across all cohorts. Patients in the automatic prescription refill program tended to take less than 1 additional chronic medication compared with the standard refill prescription cohort. The proportion of adherent patients ranged from 73.6% to 76.4% for standard refill cohorts and 77.5% to 83.6% for automatic refill cohorts. Differences between study cohorts were statistically significant for all the adherence metrics based on the chi-square test (P < 0.05). Patients enrolled in the automatic prescription refill program were more likely to be adherent to the statin (OR = 1.51, 95% CI = 1.26-1.82), RASA (OR = 1.20, 95% CI = 1.01-1.42), and diabetes (OR = 1.44, 95% CI = 1.06-1.96) metrics.
Patients enrolled in the automatic prescription refill program were more likely to be adherent to their medications. Enrollment in automatic prescription refill programs could be encouraged by health plans and pharmacists because of their potential effect on Medicare Part D star ratings.
The project described was supported by the Clinical and Translational Science Award (CTSA) program through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Lester is employed as a pharmacist in the participating pharmacy chain. The authors report no other relevant conflict of interest. Study concept and design were primarily contributed by Lester, with assistance from the other authors. Lester took the lead in data collection, along with Chui, and data interpretation was performed by Lester, Mott, and Chui. The manuscript was written primarily by Lester, along with Mott, and revised by Lester, Mott, and Chui.
医疗保险和医疗补助服务中心(CMS)在其医疗保险部分 D 星级评级计划中纳入了药物依从性的衡量标准。这些依从性措施促使开发了新的方法来提高患者的依从性。社区药房中的自动处方续配计划是近年来广泛采用的一种干预措施。这些自动续配计划以标准化、定期的方式预测并启动处方续配。因此,处方续配可能会在患者通常开始续配之前完成。本研究使用 Medicare 部分 D 星级评级中 CMS 使用的 3 种依从性指标来衡量自动处方续配计划的效果。
比较自动处方续配计划相对于标准处方续配对 Medicare 部分 D 依从性指标的价值。
使用中西部一个州的 29 家连锁药店的处方配药数据(2014 年 1 月 1 日至 2014 年 12 月 31 日)进行此分析。后设、准实验设计将患者分为自动和标准处方续配队列。使用 CMS 用于他汀类药物、肾素血管紧张素醛固酮系统拮抗剂(RASA)和非胰岛素糖尿病药物的 3 种依从性指标中的比例天数覆盖(PDC)计算续配依从性。依从率定义为 PDC ± 80%的患者比例。遵循药房质量联盟技术规范选择患者纳入标准。使用卡方分析和多因素逻辑回归检查两个研究队列之间 PDC > 80%的差异。
在他汀类药物、RASA 和糖尿病药物依从性指标中,自动续配组分别有 1018、1006 和 368 例患者,标准续配组分别有 3928、3409 和 1207 例患者。所有队列中患者的平均年龄[标准差]在 79.2 [±8.5] 岁至 80.8 [±9.9] 岁之间。与标准续配处方队列相比,自动处方续配计划中的患者服用的慢性药物通常少于 1 种。在标准续配组中,依从性患者的比例为 73.6%至 76.4%,在自动续配组中为 77.5%至 83.6%。基于卡方检验,所有依从性指标的研究队列之间的差异均具有统计学意义(P < 0.05)。参加自动处方续配计划的患者更有可能遵守他汀类药物(OR = 1.51,95%CI = 1.26-1.82)、RASA(OR = 1.20,95%CI = 1.01-1.42)和糖尿病(OR = 1.44,95%CI = 1.06-1.96)药物的医嘱。
参加自动处方续配计划的患者更有可能遵守他们的药物治疗方案。由于自动处方续配计划可能对 Medicare 部分 D 星级评级产生影响,健康计划和药剂师可以鼓励患者参加该计划。
本研究由 NIH 国家转化医学科学中心(NCATS)通过 CTSA 计划提供支持,项目编号 UL1TR000427。内容仅由作者负责,不一定代表 NIH 的官方观点。Lester 受雇于参与的连锁药房担任药剂师。作者报告没有其他相关的利益冲突。研究概念和设计主要由 Lester 提出,其他作者提供协助。Lester 主要负责数据收集,Chui 协助数据收集,数据解释主要由 Lester、Mott 和 Chui 完成。手稿主要由 Lester 撰写,Mott 协助修改,Lester、Mott 和 Chui 对其进行了修订。